Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 383

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Quantum dots: Prospectives, toxicity, advances and applications

Gidwani, Bina, Sahu, Varsha, Shukla, Shiv Shankar, Pandey, Ravindra, Joshi, Veenu, Jain, Vikas Kumar, Vyas, Amber·2021·Journal of Drug Delivery Science and Technology

Abstract

Abstract Quantum Dots are fluorescence type semiconductor nano sized particles. They are made up of either heavy metal or inorganic material with size range from 2 to 10 nm. The word quantum dots itself indicates its quantum confinement and optical properties. They contain same number of electrons and atoms, hence are called as artificial atom. Quantum dots consist of two free functional groups for binding with drug molecule. Surface modification of quantum dots through covalent and/or non-covalent binding affects and alters the properties of drug molecule. Their cellular delivery is mediated by passive transport, facilitated delivery and active transport. The outer shell of quantum dots is made of semiconductor material which provides the surface for bio-conjugation leading to improvement in aqueous solubility. This provides effective surface area for binding of drug with the targeting molecule. The unique feature being that the material of shell reduces the toxicity of core of quantum dots. Various functionalization and surface modification makes them suitable for application in pharmaceutical field such as biomedical imaging, drug delivery, drug release study and diagnosis. Toxicity of quantum dots depends upon the size, material used, dose, route of administration and capping material. The regulatory status of quantum dots is not yet clear; still they are regarded as safe to use. The first clinical trial of quantum-dot technology in humans was approved by USFDA in 2011. With the advances in technology; most of the chemotherapeutics and cytotoxic drugs are delivered as quantum dots for improved/enhanced pharmacological action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jddst.2020.102308

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Cited by

See all 383

Metadata

Authors
Gidwani, B., Sahu, V., Shukla, S. S., Pandey, R., Joshi, V., Jain, V. K., & Vyas, A.
Venue
Journal of Drug Delivery Science and Technology
Publisher
Elsevier BV
Published
2021-02
Volume
61
Pages
102308
ISSN
1773-2247 (ISSN-L)
OpenAlex
W3118434218
Cited by
383
References
81
FWCI
16.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantum dots: Prospectives, toxicity, advances and applications. https://app.cochat.ai/papers/10.1016/j.jddst.2020.102308
The paper
Gidwani, B., Sahu, V., Shukla, S. S., Pandey, R., Joshi, V., Jain, V. K., & Vyas, A. (2021). Quantum dots: Prospectives, toxicity, advances and applications. Journal of Drug Delivery Science and Technology. https://doi.org/10.1016/j.jddst.2020.102308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.